Completed PHASE3 INTERVENTIONAL 2-arm NCT00345787

Comparison of BTDS (Buprenorphine Transdermal System) and Placebo in Osteoarthritic Pain

A Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Determine the Efficacy and Safety of BTDS Compared to Placebo in Subjects With Moderate to Severe Osteoarthritic Pain of the Hip or Knee

Sponsor: Mundipharma K.K.

Conditions Osteoarthritis Pain

Interventions Buprenorphine Transdermal System Placebo

Updated 6 times since 2017 Last updated: Apr 11, 2008 Started: May 31, 2006 Primary completion: Aug 31, 2007 Completion: Aug 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Osteoarthritis and Pain, this trial is completed. The trial is conducted by Mundipharma K.K. and has accumulated 6 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

May 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mundipharma K.K.

Data source: Mundipharma Pte Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Adachi City, Japan , Annaka, Japan , Arakawa City, Japan , Chitose, Japan , Edogawa City, Japan , Fukui-shi, Japan , Hikone, Japan , Himi, Japan , Ichikawa, Japan , Isahaya, Japan and 18 more locations